Financial News

Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

104.10 -2.15 (-2.02%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 13, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Axsome Therapeutics, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

21 22 Next >

Axsome Therapeutics Stock Is Moving Lower: What's Going On?

June 28, 2023

Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading lower Wednesday after the company proposed a public offering of common stock.

Via Benzinga

2 Under-the-Radar Biotech Stocks to Buy in 2023

June 28, 2023

These companies are coming into their own.

Via The Motley Fool

The Best Stocks to Invest $20,000 in Right Now

June 28, 2023

You can invest in these companies with $20,000 -- or even a lot less.

Via The Motley Fool

Axsome Therapeutics Announces Proposed Public Offering of Common Stock

June 27, 2023

From Axsome Therapeutics, Inc.

Via GlobeNewswire

2 Low-Priced Stocks That Could Make You Richer

June 26, 2023

These two low-priced healthcare stocks could skyrocket within the next 12 months.

Via The Motley Fool

Where Will Axsome Therapeutics Be in 3 Years?

June 20, 2023

The stock soared more than 100% last year.

Via The Motley Fool

This Stock Crushed the Market Last Year. Here's Why It Could Do That Again.

June 16, 2023

This small biotech could become much bigger in just a few years.

Via The Motley Fool

Is Axsome Therapeutics Stock a Screaming Buy?

June 15, 2023

The biotech could be staring down an enormous commercial opportunity.

Via The Motley Fool

3 Monster Stocks in the Making to Buy Right Now

June 25, 2023

They're not monsters now -- but just give them some time.

Via The Motley Fool

3 Biotech Stocks to Buy as Companies Ink Major Deals

June 22, 2023

Pharmaceutical and biotech companies will soon face generic competition, creating big opportunity for these top biotech stocks to buy.

Via InvestorPlace

Does an $11.5 Billion Opportunity Make This Growth Stock a Buy Now?

June 17, 2023

Soaring sales of a new depression treatment could be just the tip of the iceberg for Axsome Therapeutics.

Via The Motley Fool

Stock Market Rally Runs Through Hawkish Fed; Adobe, Lennar, Oracle, UnitedHealth In Focus: Weekly Review

June 16, 2023

Stocks kept powering higher despite, but the Nasdaq is looking extended.

Via Investor's Business Daily

Why Axsome Therapeutics Stock Is Rising Today

June 14, 2023

Axsome Therapeutics, Inc. (NASDAQ: AXSM) shares are trading higher Wednesday following a recent corporate presentation.

Via Benzinga

Analyst Expectations for Axsome Therapeutics's Future

June 12, 2023

Via Benzinga

Axsome Therapeutics's Return On Capital Employed Overview

May 22, 2023

Via Benzinga

3 Growth Stocks to Buy and Hold

May 13, 2023

These three stocks defied the bear market last year.

Via The Motley Fool

Axsome Therapeutics Expects Up To $11.5 Billion In Peak Sales, Wallops Analysts' Forecasts

June 14, 2023

The company's biggest products treats depression and could be used in other conditions.

Via Investor's Business Daily

3 No-Brainer Stocks to Buy in June

June 10, 2023

These biopharma stocks could be big winners.

Via The Motley Fool

The Top Healthcare Stocks to Buy With $100

June 09, 2023

You don't need a fortune to start investing.

Via The Motley Fool

Axsome Therapeutics to Present New Sunosi® Data at SLEEP 2023

June 01, 2023

Cognitive improvement with Sunosi sustained over eight hours in patients with excessive daytime sleepiness due to obstructive sleep apnea

From Axsome Therapeutics, Inc.

Via GlobeNewswire

Axsome Therapeutics to Present Data and Post-Hoc Analyses on Auvelity® and Sunosi® at the 2023 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

May 30, 2023

From Axsome Therapeutics, Inc.

Via GlobeNewswire

Prediction: These 2 Stocks Could Double In the Next Year

May 28, 2023

It would be a continuation of solid recent performances.

Via The Motley Fool

2 Biotech Stocks That Could Help Set You Up for Life

May 26, 2023

These two promising companies have the potential to beat the market over time.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session

May 22, 2023

Via Benzinga

2 Bear Market Defying Stocks to Buy in May

May 22, 2023

These stocks still have plenty of market-beating years ahead.

Via The Motley Fool

2 Unstoppable Growth Stocks to Buy in 2023 and Beyond

May 20, 2023

Both Axsome Therapeutics and Exelixis have potentially game-changing products in their pipelines.

Via The Motley Fool

Is a Victory for Its Rivals Bad News for Axsome Therapeutics?

May 17, 2023

The biopharmaceutical company's shares have soared during the past year.

Via The Motley Fool

Market Rally Diverges; Google Surges On AI News, Inflation Cools, But Breadth Weak: Weekly Review

May 12, 2023

The Nasdaq hit a new 2023 high, but not the S&P 500 or Dow Jones.

Via Investor's Business Daily

This Analyst Creates Bullish Pitch For Axsome Therapeutics On Increased Outlook For Its Depression Drug

May 11, 2023

Mizuho increased the price target on Axsome Therapeutics Inc (NASDAQ: AXSM) from $84 to $95 with a Buy rating

Via Benzinga

2 Magnificent Growth Stocks You Can Buy With $150 Right Now

May 10, 2023

You don't have to wait until you're rich to start getting your money to work for you.

Via The Motley Fool

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Financial News

Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

All News about Axsome Therapeutics, Inc. - Common Stock

Popular Pages